20 March 2015 Signal enhancement ratio (SER) quantified from breast DCE-MRI and breast cancer risk
Author Affiliations +
Abstract
Breast magnetic resonance imaging (MRI) is recommended as an adjunct to mammography for women who are considered at elevated risk of developing breast cancer. As a key component of breast MRI, dynamic contrast-enhanced MRI (DCE-MRI) uses a contrast agent to provide high intensity contrast between breast tissues, making it sensitive to tissue composition and vascularity. Breast DCE-MRI characterizes certain physiologic properties of breast tissue that are potentially related to breast cancer risk. Studies have shown that increased background parenchymal enhancement (BPE), which is the contrast enhancement occurring in normal cancer-unaffected breast tissues in post-contrast sequences, predicts increased breast cancer risk. Signal enhancement ratio (SER) computed from pre-contrast and post-contrast sequences in DCE-MRI measures change in signal intensity due to contrast uptake over time and is a measure of contrast enhancement kinetics. SER quantified in breast tumor has been shown potential as a biomarker for characterizing tumor response to treatments. In this work we investigated the relationship between quantitative measures of SER and breast cancer risk. A pilot retrospective case-control study was performed using a cohort of 102 women, consisting of 51 women who had diagnosed with unilateral breast cancer and 51 matched controls (by age and MRI date) with a unilateral biopsy-proven benign lesion. SER was quantified using fully-automated computerized algorithms and three SER-derived quantitative volume measures were compared between the cancer cases and controls using logistic regression analysis. Our preliminary results showed that SER is associated with breast cancer risk, after adjustment for the Breast Imaging Reporting and Data System (BI-RADS)-based mammographic breast density measures. This pilot study indicated that SER has potential for use as a risk factor for breast cancer risk assessment in women at elevated risk of developing breast cancer.
© (2015) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Shandong Wu, Shandong Wu, Brenda F. Kurland, Brenda F. Kurland, Wendie A. Berg, Wendie A. Berg, Margarita L. Zuley, Margarita L. Zuley, Rachel C. Jankowitz, Rachel C. Jankowitz, Jules Sumkin, Jules Sumkin, David Gur, David Gur, } "Signal enhancement ratio (SER) quantified from breast DCE-MRI and breast cancer risk", Proc. SPIE 9414, Medical Imaging 2015: Computer-Aided Diagnosis, 94140M (20 March 2015); doi: 10.1117/12.2082466; https://doi.org/10.1117/12.2082466
PROCEEDINGS
6 PAGES


SHARE
Back to Top